CAREDX, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
CAREDX, INC. (CDNA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $9.08 per share for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Notes › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2025-02-28
- CAREDX, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2017-06-30 was $0.52, a 74.13% decline year-over-year.
- CAREDX, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2017-03-31 was $1.20, a 42.03% decline year-over-year.
- CAREDX, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2016-09-30 was $2.18, a 22.42% decline year-over-year.
- CAREDX, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2016-06-30 was $2.01, a 4.29% decline year-over-year.
- CAREDX, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2024 was $9.08, a 5.21% increase from fiscal 2023.
- CAREDX, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2023 was $8.63, a 55.77% decline from fiscal 2022.
- CAREDX, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2022 was $19.51, a 62.94% decline from fiscal 2021.
- CAREDX, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2021 was $52.65, a 177.54% increase from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month |
|---|---|---|---|---|
| 2024-12-31 | $9.08 10-K · filed 2025-02-28 | |||
| 2023-12-31 | $8.63 10-K · filed 2025-02-28 | |||
| 2022-12-31 | $19.51 10-K · filed 2025-02-28 | |||
| 2021-12-31 | $52.65 10-K · filed 2024-02-28 | |||
| 2020-12-31 | $18.97 10-K · filed 2023-02-27 | |||
| 2019-12-31 | $17.74 10-K · filed 2022-02-24 | |||
| 2018-12-31 | $9.05 10-K · filed 2021-02-24 | |||
| 2017-12-31 | $1.60 10-K · filed 2020-02-28 | |||
| 2017-06-30 | $0.52 10-Q · filed 2017-08-11 | $1.00 10-Q · filed 2017-08-11 | ||
| 2017-03-31 | $1.20 10-Q · filed 2017-06-09 | |||
| 2016-12-31 | $2.05 10-K · filed 2019-03-06 | |||
| 2016-09-30 | $2.18 10-Q · filed 2016-11-14 | $2.08 10-Q · filed 2016-11-14 | ||
| 2016-06-30 | $2.01 10-Q · filed 2017-08-11 | $2.06 10-Q · filed 2017-08-11 | ||
| 2016-03-31 | $2.07 10-Q · filed 2017-06-09 | |||
| 2015-12-31 | $2.53 10-K · filed 2018-03-22 | |||
| 2015-09-30 | $2.81 10-Q · filed 2016-11-14 | $2.63 10-Q · filed 2016-11-14 | ||
| 2015-06-30 | $2.10 10-Q · filed 2016-08-22 | $2.62 10-Q · filed 2016-08-22 | ||
| 2015-03-31 | $2.76 10-Q · filed 2016-05-16 | |||
| 2014-12-31 | $4.81 10-K · filed 2017-04-21 | |||
| 2014-09-30 | $5.07 10-Q · filed 2014-11-14 | |||
| 2014-06-30 | $4.94 10-Q · filed 2014-08-28 | |||
| 2013-12-31 | $0.21 10-K · filed 2016-03-29 | |||
| 2012-12-31 | $0.27 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |